Search
Search your stock
Analysis
Teva Pharmaceutical Industries Limited (TEVA)
Teva Pharmaceutical Industries Limited (TEVA)
Ranking:
Sell
Implies negative momentum
Stock Name: Teva Pharmaceutical Industries Limited
Symbol: TEVA
Market Cap: $19.62B
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.tevapharm.com
About Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients Please visit their website for more information.

Overview:
Last Close: $17.29
52 Week: $12.01-$22.77
MVA50: 19.54
MVA200: 17.46
Quarterly Revenue: $4.23B
RSI: 28.00
Buy/Sell*: 3.23
1-Month change: -28.46%
3-Month change: -0.98%
EPS: -0.19
*Proprietary Buy Sell Volume Indicator
Price Chart For TEVA
Our Approach

Our proprietary analysis employs a weighted average approach integrating both functional and technical parameters, tailored to the sector, industry, and microeconomic factors. This methodology assigns dynamic weights to the parameters, with a focus on recent trends, ensuring a nuanced evaluation for informed investment decisions. Considering various financial parameters of the stock from its income statement, balance sheet, and cash flow, in addition to some of the derived parameters of the stock in conjunction with its sector and macroeconomic conditions, our proprietary Weighted Average AI model gives a rank of Sell.

TheoryofStocks is not registered as an investment advisor with any regulatory authority. The information provided on this Website is for educational purposes only and should not be construed as financial or investment advice. By continuing to use this site, you are agreeing to the Terms of Use and Privacy Policy. Please read our Disclaimer.

Contact @ support@theoryofstocks.com

© 2024 Stock Articles. All rights reserved.

This site uses cookies to ensure the best experience. By continuing to use this site, you agree to their use.

Click here for Cookie Policy